[VIR] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[VIR] Vir Biotechnology, Inc.
Announcement Date
03-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 329.19%
YoY- 58.76%
Quarter Report
VIR's Result
VIR's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue -12,722 46,712 21,789 371,432 -42,687 1,229,938 809,756 -
PBT -197,623 -143,188 -151,638 217,732 -233,721 921,907 545,889 -
Tax -2,848 -2,232 -50,035 42,420 -157,228 403,286 20,635 -
NP -194,775 -140,956 -101,603 175,312 -76,493 518,621 525,254 -
Tax Rate - - - -19.48% - -43.74% -3.78% -
Total Cost 182,053 187,668 123,392 196,120 33,806 711,317 284,502 -25.80%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 1,531.01 -301.76 -466.30 47.20 179.20 42.17 64.87 727.56%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -1.45 -1.06 -0.76 1.32 -0.58 3.93 4.01 -
EPS Diluted -1.45 -1.06 -0.76 1.30 -0.58 3.85 3.92 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.